Humana’s 2026 Medicare Advantage and Prescription Drug Plans emphasize simplicity, stability, and expanded access, with lowered premiums and enhanced benefits for Medicare beneficiaries nationwide.

AARP's nonpartisan advocacy efforts focus on protecting Medicare and Social Security amid funding challenges and policy changes. Learn about recent campaigns and member engagement strategies.

Trilogy Health Services CMO discusses Medicare Advantage's impact on skilled nursing, focusing on administrative challenges, appeals, and value-based care opportunities. Insights on I-SNP partnerships and payment simplification for providers.

UnitedHealth Group maintains strong 2026 Medicare Advantage Stars ratings and reaffirms 2025 earnings guidance, signaling stability amid market challenges.

Explore the impact of major Medicaid cuts, ACA subsidy eliminations, nursing home funding delays, and healthcare cost increases following the 2026 federal budget changes affecting the U.S. healthcare system.

UnitedHealth Group settles with US Justice Department requiring divestiture of 164 home health and hospice facilities in $3.3 billion Amedisys acquisition to maintain market competition and compliance.

Centene withdraws 2025 earnings forecast amid ACA challenges and faces potential credit downgrade. Elevance Health reports declining income. AI tech growth drives demand for energy infrastructure, presenting new investment angles.

UnitedHealth Group faces lawsuits and federal probes over AI-driven claims denials in Medicare Advantage, highlighting regulatory risks and the need for ethical plan advisory.

Astrana Health's Q1 2025 earnings reveal revenue growth offset by margin compression due to Medicaid utilization and integration investments. Key focus on full-risk contracts and regulatory renewals.

UnitedHealth Group's stock has dropped over 50% in 2024 amid operational disruptions and DOJ probes, despite strong ROCE. Insights on regulatory risks, Medicare cost pressures, and valuation outlook for investors.